Evidence for the Additional Health Benefits Associated with Phosphodiesterase 5 Inhibitors when Used for Treating Erectile Dysfunction, with a Focus on Prostate Cancer Patients and Other Associated Conditions.
Saved in:
| Title: | Evidence for the Additional Health Benefits Associated with Phosphodiesterase 5 Inhibitors when Used for Treating Erectile Dysfunction, with a Focus on Prostate Cancer Patients and Other Associated Conditions. |
|---|---|
| Authors: | Naranjo A; Prostate Cancer UK, London, UK. alexandra.naranjo@prostatecanceruk.org., Hackett GI; Aston University Medical School, Birmingham, UK., Smith S; Prostate Cancer UK, London, UK., Stephens H; Bristol Cancer Institute, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK., Kinnaird W; Cancer Division, University College London Hospitals NHS Foundation Trust, London, UK., Kirby M; Prostate Cancer UK, London, UK. |
| Source: | The world journal of men's health [World J Mens Health] 2026 Jul; Vol. 44 (3), pp. 582-592. Date of Electronic Publication: 2026 Feb 13. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Korean Society for Sexual Medicine and Andrology Country of Publication: Korea (South) NLM ID: 101596899 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2287-4208 (Print) Linking ISSN: 22874208 NLM ISO Abbreviation: World J Mens Health Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2287-4208 |
|---|---|
| DOI: | 10.5534/wjmh.250313 |
